11 completed, 2 terminated, 1 enrolling by invitation, 1 recruiting. 16 Phase 3, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 16 | Completed 11, Terminated 2, Enrolling by invitation 1, Recruiting 1, Unknown 1 |
| Phase 2 | 5 | Completed 4, Enrolling by invitation 1 |
Follow Nitric Oxide: new trials by email Literature Review of Nitric Oxide trials Research Report on Nitric Oxide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution NCX 470, Placebo - Open Angle Glaucoma | Phase 2 / Phase 3 | Completed | Nicox Ophthalmics, Inc. | 18 | 2023-12-12 | 2025-09-08 |
| NO During CPB in Neonates to Reduce Risk of AKI Nitric Oxide, Oxygen - AKI, CHD - Congenital Heart Disease | Phase 3 | Recruiting | Children's Hospital Medical Center, Cincinnati | 40 | 2023-01-10 | 2026-08-05 |
| Nitric Oxide Effect on Brain and Kidney in Pediatric Patients Undergoing Cardiopulmonary Bypass Nitric Oxide (NO) 20 part per million (ppm), Standard of care cardiopulmonary bypass - Congenital Heart Disease, Congenital Heart Defect | Phase 2 / Phase 3 | Enrolling by invitation | Vanderbilt University Medical Center | 50 | 2022-04-25 | 2025-10-08 |
| Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection Nitric Oxide, Nasal spray with isotonic saline - SARS-CoV-2 Infection | Phase 3 | Terminated | Sanotize Research and Development corp. | 1389 | 2021-11-20 | 2025-09-25 |
| Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Mild COVID-19 Nitric Oxide - SARS-CoV-2 Infection | Phase 3 | Completed | Sanotize Research and Development corp. | 306 | 2021-11-01 | 2022-10-31 |
| Nitric Oxide During Cardiopulmonary Bypass in Adult Surgery Nitric Oxide, standard of care treatment - Hypoxia | Phase 3 | Unknown | Rabin Medical Center | 300 | 2021-08-14 | 2021-10-08 |
| Nitric Oxide During Bypass for Arterial Switch Operation Nitric Oxide - Low Cardiac Output Syndrome, Transposition of Great Vessels | Phase 3 | Completed | Murdoch Childrens Research Institute | 300 | 2018-07-11 | 2024-04-18 |
| Nitric Oxide Administration During Pediatric Cardiopulmonary Bypass Surgery to Prevent Platelet Activation Nitric Oxide, Placebo, INOmax - Inflammation, Platelet Dysfunction | Phase 2 / Phase 3 | Completed | Medical College of Wisconsin | 40 | 2018-04-25 | 2020-08-13 |
| Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis Nitric Oxide, Supportive treatment - Bronchiolitis | Phase 3 | Completed | Beyond Air Inc. | 69 | 2017-03-05 | 2019-07-09 |
| Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction. Nitric Oxide, Placebo - Acute Kidney Injury | Phase 3 | Completed | Massachusetts General Hospital | 250 | 2017-02-08 | 2026-03-10 |
| Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia Nitric Oxide, respiratory support - Pulmonary Disease | Phase 2 / Phase 3 | Completed | Fudan University | 400 | 2011-05-01 | 2013-01-28 |
| Effect of Inhaled Nitric Oxide in Acute Chest Syndrome (INOSTA Study) Nitric Oxide, Placebo - Sickle Cell Disease, Acute Chest Syndrome | Phase 2 / Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 100 | 2008-12-01 | 2013-08-02 |
| Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies Nitric oxide, Placebo - Lung Disease | Phase 3 | Completed | Mallinckrodt | 800 | 2005-05-29 | 2021-02-05 |
| Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing Nitric Oxide for inhalation, Oxygen, Nitric Oxide plus Oxygen - Idiopathic Pulmonary Arterial Hypertension, Cardiomyopathy | Phase 3 | Completed | Mallinckrodt | 136 | 2004-09-01 | 2019-12-20 |
| Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation nitric oxide for inhalation, Placebo - Ischemia-Reperfusion Injury | Phase 3 | Terminated | Mallinckrodt | 84 | 2001-08-01 | 2016-09-09 |
| Nitric Oxide Administration for Acute Respiratory Distress Syndrome Nitric Oxide, No Intervention - Acute Respiratory Distress Syndrome | Phase 3 | Completed | Children's Hospital of Philadelphia | 52 | 2000-09-01 | 2015-04-24 |
Heart Defects, Congenital (4) · Acute Lung Injury (2) · COVID-19 (2) · Lung Diseases (2) · Acute Chest Syndrome (1) · Acute Kidney Injury (1) · Anemia, Sickle Cell (1) · Bronchiolitis (1) · Bronchopulmonary Dysplasia (1) · Cardiac Output, Low (1) · Cardiomyopathies (1) · Familial Primary Pulmonary Hypertension (1) · Glaucoma (1) · Glaucoma, Open-Angle (1) · Hypoxia (1)
Mallinckrodt (3) · Sanotize Research and Development corp. (2) · Assistance Publique - Hôpitaux de Paris (1) · Beyond Air Inc. (1) · Children's Hospital Medical Center, Cincinnati (1) · Children's Hospital of Philadelphia (1) · Fudan University (1) · Massachusetts General Hospital (1) · Medical College of Wisconsin (1) · Murdoch Childrens Research Institute (1) · Nicox Ophthalmics, Inc. (1) · Rabin Medical Center (1) · Vanderbilt University Medical Center (1)
United States (8) · France (3) · Canada (2) · Israel (2) · Netherlands (2) · Spain (2) · United Kingdom (2) · Australia (1) · Belgium (1) · China (1) · Finland (1) · Germany (1) · India (1) · Indonesia (1) · Italy (1)
Keith Moore, PHARMD (2) · Bo Sun, Ph.D (1) · David P Bichell, MD (1) · Leonid Eidelman (1) · Lorenzo Berra, MD (1) · Neil MacIntyre, MD (1) · Rodolfo I Godinez, MD, PhD (1) · Warwick Butt (1)
PMID 20405117, PMID 20655106, PMID 23228403, PMID 23940237, PMID 26431718, PMID 27686343, PMID 28046032, PMID 31278097, PMID 32541773, PMID 39037709, PMID 41270263
2004 (2), K23HL128882 (1)